Bovine Parainfluenza Virus 3, Reisinger(Nl-Bk-6), Mlv; Bovine Respiratory Syncyt

237 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

237

Total Reports

192

Deaths Reported

8100.0%

Death Rate

Active Ingredients

Bovine Parainfluenza Virus 3, Reisinger(Nl-Bk-6), Mlv; Bovine Respiratory Syncyt

Administration Routes

SubcutaneousIntramuscularUnknown

Species Affected

Cattle 234

Unknown 3

Most Affected Breeds

Cattle (other) 143

Mixed (Cattle) 30

Holstein-Friesian also known as Holstein 21

Aberdeen Angus 14

Crossbred Bovine/Cattle 13

Hereford cattle 3

Cattle (unspecified) 3

Cattle (unknown) 3

Unknown 3

Gelbvieh 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 162

Death 140

Lack of efficacy - NOS 43

CULTURE/TITER DATA ABNORMAL 25

Other abnormal test result NOS 23

Abnormal test result 21

Increased mortality rate 18

PR-LUNG(S), LESION(S) 14

Abnormal necropsy finding 14

NT - Abnormal necropsy finding NOS 14

NT - fibrinous (broncho) pneumonia/fibrinous pleuropneumonia 12

DEATH-TREATMENT FAILURE 8

Outcome Breakdown

Died

192 (47.8%)

Outcome Unknown

147 (36.6%)

Recovered/Normal

26 (6.5%)

Ongoing

23 (5.7%)

Recovered with Sequela

10 (2.5%)

Euthanized

4 (1.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.